Magrolimab Plus Rituximab with/without Chemotherapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Maakaron J, Asch AS, Popplewell L, Collins GP, Flinn IW, Ghosh N, Keane C, Ku M, Mehta A, Roschewski M, Hacohen-Kleiman G, Huo Y, Zhang Y, Renard C, Smith SM, Advani RH.
Maakaron J, et al. Among authors: smith sm.
Blood Adv. 2024 Sep 18:bloodadvances.2024013338. doi: 10.1182/bloodadvances.2024013338. Online ahead of print.
Blood Adv. 2024.
PMID: 39293083